Blockbuster Weight-Loss Drugs & Cancer Risk: Ozempic Can Affect Pancreas Cells, Experts Weigh In On Whether That’s Worrisome

Published Feb 22, 2025

Blockbuster Weight-Loss Drugs & Cancer Risk: Ozempic Can Affect Pancreas Cells, Experts Weigh In On Whether That’s Worrisome

These concerns were initially addressed in 2013 by the U.S. Food and Drug Administration (FDA), well before Ozempic's use skyrocketed in mid-2022 as a revolutionary diet drug in Hollywood

×
NOW
PLAYING
20-Year-Old College Student Dismissed 'High Heart Rate' & 'Tight Chest' As Anxiety. It Was Pancreatic Cancer—Now She’s Pushing For Early Detection
NOW
PLAYING
Ozempic Horror Story: 'Kinda Pregnant' Star & Beloved Comedian Amy Schumer, 43, Was 'Bedridden' & 'Vomiting' -- The Risks Of Blockbuster Weight Loss Drugs
NOW
PLAYING
California Mom's Desperate Effort To Remove Flawed Breast Implants She Got After Preventative Mastectomy: Her Eight Year Struggle & Expert Guidance For Women With Implants
NOW
PLAYING
The 'Dexter' Origin Story: Michael C. Hall Is Back in the New 'Original Sin' Series, 15 Years After His Real Life Lymphoma Battle
NOW
PLAYING
Doctor Says Weight Loss Drugs Provide 'More Durable Weight Loss Than Lifestyle Interventions' - Understanding Obesity & Cancer Risk
NOW
PLAYING
Prevention For Pancreatic Cancer That Took Alex Trebek? New Data Shows GLP-1 Drugs, Like Ozempic, Linked to 53% Drop

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW

AI-Powered by My Health Questions

Built by medical professionals

Want to dive deeper into this article?

Try asking any of the questions below:

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider